Summit Therapeutics
SMMT
SMMT
55 hedge funds and large institutions have $13.6M invested in Summit Therapeutics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 20
42% less capital invested
Capital invested by funds: $23.3M → $13.6M (-$9.7M)
Holders
55
Holding in Top 10
–
Calls
$135K
Puts
$51K
Top Buyers
| 1 | +$538K | |
| 2 | +$348K | |
| 3 | +$216K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$115K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$52K |
Top Sellers
| 1 | -$249K | |
| 2 | -$146K | |
| 3 | -$72K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$40.7K |
| 5 |
SG Americas Securities
New York
|
-$28.3K |